QNRX: Quoin Pharmaceuticals Ltd. Amount of Cash per Share

Corporate emblem and logo of Quoin Pharmaceuticals Ltd (QNRX)

Quoin Pharmaceuticals' focus on patents within the orphan dermatology niche drives its financial dynamics. Cash per share visualizes current capital, where 6.91 reflects the latest value of the metric. Diversified European and US manufacturing outsourcing reduces logistical risks, although high development costs and dependence on clinical outcomes create certain pressure on balance sheet liquidity.

QNRX (quoinpharma.com) Cash per Share history from 07/04/2022 to 11/21/2026

Analytical breakdowns for Quoin Pharmaceuticals

- current price and projected stock value:
- market capitalization information:
Comprehensive company analysis:QNRX Quoin Pharmaceuticals Ltd.
Core merchandise of Quoin Pharmaceuticals

Cash per share determines the level of direct liquidity available to each security holder. Daily recalculations eliminate accounting lags, capturing real-time changes in the volume of free cash. By analyzing the cash per share figure, an investor assesses protection against liquidity gaps. Growth in this metric is critically important for Quoin Pharmaceuticals (QNRX), as it ensures the funding for the development of drugs to treat rare skin pathologies.